Alligator Bioscience AB - Product Pipeline Review - 2014

Published: Jul, 2014 | Pages: 28 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Alligator Bioscience AB - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Alligator Bioscience AB - Product Pipeline Review - 2014', provides an overview of the Alligator Bioscience AB's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Alligator Bioscience AB's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Alligator Bioscience AB including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Alligator Bioscience AB's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Alligator Bioscience AB's pipeline products

Reasons to buy

- Evaluate Alligator Bioscience AB's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Alligator Bioscience AB in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Alligator Bioscience AB's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Alligator Bioscience AB and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Alligator Bioscience AB
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Alligator Bioscience AB and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Alligator Bioscience AB Snapshot 5
Alligator Bioscience AB Overview 5
Key Information 5
Key Facts 5
Alligator Bioscience AB - Research and Development Overview 6
Key Therapeutic Areas 6
Alligator Bioscience AB - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Alligator Bioscience AB - Pipeline Products Glance 12
Alligator Bioscience AB - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Discovery Products/Combination Treatment Modalities 13
Alligator Bioscience AB - Drug Profiles 14
ADC-1004 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
ADC-1013 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
ADC-1014 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
ADC-1015 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Drug for Undisclosed Indication 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
ADC-1016 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Alligator Bioscience AB - Pipeline Analysis 20
Alligator Bioscience AB - Pipeline Products by Target 20
Alligator Bioscience AB - Pipeline Products by Route of Administration 21
Alligator Bioscience AB - Pipeline Products by Molecule Type 22
Alligator Bioscience AB - Pipeline Products by Mechanism of Action 23
Alligator Bioscience AB - Recent Pipeline Updates 24
Alligator Bioscience AB - Dormant Projects 25
Alligator Bioscience AB - Locations And Subsidiaries 26
Head Office 26
Appendix 27
Methodology 27
Coverage 27
Secondary Research 27
Primary Research 27
Expert Panel Validation 27
Contact Us 28
Disclaimer 28

List of Tables
Alligator Bioscience AB, Key Information 5
Alligator Bioscience AB, Key Facts 5
Alligator Bioscience AB - Pipeline by Indication, 2014 7
Alligator Bioscience AB - Pipeline by Stage of Development, 2014 8
Alligator Bioscience AB - Monotherapy Products in Pipeline, 2014 9
Alligator Bioscience AB - Partnered Products in Pipeline, 2014 10
Alligator Bioscience AB - Partnered Products/ Combination Treatment Modalities, 2014 11
Alligator Bioscience AB - Preclinical, 2014 12
Alligator Bioscience AB - Discovery, 2014 13
Alligator Bioscience AB - Pipeline by Target, 2014 20
Alligator Bioscience AB - Pipeline by Route of Administration, 2014 21
Alligator Bioscience AB - Pipeline by Molecule Type, 2014 22
Alligator Bioscience AB - Pipeline Products by Mechanism of Action, 2014 23
Alligator Bioscience AB - Recent Pipeline Updates, 2014 24
Alligator Bioscience AB - Dormant Developmental Projects,2014 25